Male Breast Cancer Prognostic Factors Versus Female Counterparts with Propensity Scores and Matched-Pair Analysis

• Published in: Curēus (Palo Alto, CA) CA), 2015-10, Vol.7 (10), p.e355-e355
• Main Authors: Yu, Edward, Stitt, Larry, Vujovic, Olga, Joseph, Kurian, Assouline, Avi, Younus, Jawaid, Perera, Francisco, Tai, Patricia
• Format: Article
• Language: English
• Subjects: Oncology; Radiation Oncology
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.355

To assess the effect of prognostic factors and their impact on survival in male and female breast cancer. Medical records for men and women diagnosed with breast cancer referred to the cancer center for treatment were reviewed. Patients with distant metastatic diseases were excluded. Data on prognostic factors including age, nodal status, resection margin, use of hormonal therapy, chemotherapy with and without hormone and radiation therapy (RT), survival, and recurrence were analyzed. Survival estimates were obtained using Kaplan-Meier methodology. The Cox regression interaction was used to compare male and female differences in prognostic factors. Male breast cancer (MBC) and female breast cancer (FBC) were matched according to propensity scores and survival compared using Cox regression. From 1963-2006, there were 75 MBC and 1,313 FBC totaling 1,388 breast cancers. The median age of the cohort was 53 (range: 23-90) years. Median follow-up was 90 (range: 0.4-339) months. Prognostic factors of patients were balanced among the groups after adjusting for propensity scores. A Cox model adjusting for propensity scores showed that overall survival (OS) (HR= 2.52 (1.65, 3.86), P